A data-driven approach for the discovery of biomarkers associated with thyroid eye disease

被引:3
作者
Zou, Huihui [1 ]
Xu, Weiwei [1 ]
Wang, Ying [2 ]
Wang, Zhihong [1 ]
机构
[1] Dezhou Peoples Hosp, Dept Ophthalmol, Dezhou 253000, Peoples R China
[2] Dezhou Womens & Childrens Hosp, Dept Ophthalmol, Dezhou, Shandong, Peoples R China
关键词
Thyroid eye disease; Autoimmune disease; Biomarker; Graves’ disease; INTERLEUKIN-RELATED GENES; GRAVES OPHTHALMOPATHY; ORBITAL DECOMPRESSION; PATHOGENESIS; RECEPTOR; SMOKING; PATHWAY; UPDATE; TSH;
D O I
10.1186/s12886-021-01903-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Thyroid eye disease (TED) is the most common autoimmune disease and usually occurs in patients with hyperthyroidism. In this disease, eye-related tissue, such as eye muscles, eyelids, tear glands, etc., become inflated, which causes the eyes and eyelids to become red, swollen, and uncomfortable. The pathophysiology of this disease is still poorly known. Aim This study aims to discover potential biomarkers and regulatory pathways of TED which will not only help to diagnose the disease and understand orbital involvement in thyroid dysfunction but also provide an insight for better therapeutics. Methods We applied a data-driven approach by combining gene biomarkers both from published literature and computationally predicted from microarray gene expression data. Further, the DAVID tool is used for Gene Ontology-based enrichment analysis. Results We obtained a total of 22 gene biomarkers, including 18 semi-automatically curated from the literature and 4 predicted using data-driven approaches, involved in the pathogenesis of TED that can be used as potential information for therapeutic targets. Further, we constructed a regulatory pathway of TED biomarkers comprises of 310 connected components, and 1134 interactions using four prominent interaction databases. Conclusion This constructed pathway can be further utilized for disease dynamics and simulation studies.
引用
收藏
页数:10
相关论文
共 59 条
[1]  
Abraham P, 2010, THER CLIN RISK MANAG, V6, P29
[2]  
[Anonymous], 2020, REPORTLINKER
[3]   Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management [J].
Barrio-Barrio, Jesus ;
Sabater, Alfonso L. ;
Bonet-Farriol, Elvira ;
Velazquez-Villoria, Alvaro ;
Galofre, Juan C. .
JOURNAL OF OPHTHALMOLOGY, 2015, 2015
[4]   Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search [J].
Boboridis, Konstadinos G. ;
Uddin, Jimmy ;
Mikropoulos, Dimitrios G. ;
Bunce, Catey ;
Mangouritsas, George ;
Voudouragkaki, Irini C. ;
Konstas, Anastasios G. P. .
ADVANCES IN THERAPY, 2015, 32 (07) :595-611
[5]  
Bothun ED, 2009, CLIN OPHTHALMOL, V3, P543
[6]   IL-1β induces IL-6 expression in human orbital fibroblasts:: Identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy [J].
Chen, BL ;
Tsui, S ;
Smith, TJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :1310-1319
[7]   Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes [J].
Chen, Hong ;
Mester, Tuende ;
Raychaudhuri, Nupur ;
Kauh, Courtney Y. ;
Gupta, Shivani ;
Smith, Terry J. ;
Douglas, Raymond S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09) :E1635-E1640
[8]   General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD [J].
Chen Xiaoheng ;
Mei Yizhou ;
He Bei ;
Li Huilong ;
Wang Xin ;
Hu Rui ;
Li Lu ;
Ding Zhiguo .
MEDIATORS OF INFLAMMATION, 2017, 2017
[9]   The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens [J].
Clarke, Fiona ;
Purvis, Harriet A. ;
Sanchez-Blanco, Cristina ;
Gutierrez-Martinez, Enrique ;
Cornish, Georgina H. ;
Zamoyska, Rose ;
Guermonprez, Pierre ;
Cope, Andrew P. .
SCIENTIFIC REPORTS, 2018, 8
[10]  
Degroot Leslie J., 1996, The thyroid and its diseases. Chapter 10.Graves disease and its manifestations, V6th, P371